Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $0.14 in the prior trading day, Applied Dna Sciences Inc (NASDAQ: APDN) closed at $0.13, down -7.78%. In other words, the price has decreased by -$7.78 from its previous closing price. On the day, 2.08 million shares were traded.
Ratios:
Our goal is to gain a better understanding of APDN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.53 and its Current Ratio is at 4.72. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH Capital on February 12, 2021, initiated with a Buy rating and assigned the stock a target price of $24.
On January 14, 2021, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $18 to $14.
H.C. Wainwright reiterated its Buy rating for the stock on December 18, 2020, while the target price for the stock was revised from $20 to $12.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.89 while its Price-to-Book (P/B) ratio in mrq is 0.54.
Stock Price History:
Over the past 52 weeks, APDN has reached a high of $11.76, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -29.05%, while the 200-Day Moving Average is calculated to be -77.13%.
Shares Statistics:
A total of 54.11M shares are outstanding, with a floating share count of 51.42M. Insiders hold about 6.82% of the company’s shares, while institutions hold 39.58% stake in the company.
Earnings Estimates
The stock of Applied Dna Sciences Inc (APDN) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.48 and -$0.48 for the fiscal current year, implying an average EPS of -$0.48. EPS for the following year is -$0.11, with 1.0 analysts recommending between -$0.11 and -$0.11.
Revenue Estimates
1 analysts predict $1.19M in revenue for the current quarter. It ranges from a high estimate of $1.19M to a low estimate of $1.19M. As of the current estimate, Applied Dna Sciences Inc’s year-ago sales were $929.63kFor the next quarter, 1 analysts are estimating revenue of $1.28M. There is a high estimate of $1.28M for the next quarter, whereas the lowest estimate is $1.28M.
A total of 1 analysts have provided revenue estimates for APDN’s current fiscal year. The highest revenue estimate was $5.28M, while the lowest revenue estimate was $5.28M, resulting in an average revenue estimate of $5.28M. In the same quarter a year ago, actual revenue was $3.43MBased on 1 analysts’ estimates, the company’s revenue will be $7.4M in the next fiscal year. The high estimate is $7.4M and the low estimate is $7.4M.
